Elevate Holistics' 2025 Cannabis Research Reveals New Therapeutic Insights Led by CEO Aspen Noonan
Elevate Holistics' 2025 Medical Cannabis Research Insights
Introduction
In a landmark announcement, Elevate Holistics, a telehealth platform specializing in medical cannabis, has unveiled significant findings from its recent research efforts in 2025. Under the direction of CEO Aspen Noonan, the company aims to bolster its commitment to providing safe and accessible medical cannabis solutions. This article delves into the research outcomes, implications for patient care, and the pivotal strategies orchestrated by Noonan to enhance the company's mission.
Key Findings from 2025 Research
According to a recent meta-analysis published in the journal Frontiers in Oncology, cannabis exhibits impressive positive correlations when it comes to managing symptoms in cancer patients. This corroborates the growing body of evidence indicating the antitumor potential of cannabis-based therapies. In just the first half of 2025, over 160 peer-reviewed studies emerged, reflecting an expanded understanding of cannabinoids like THC, CBD, CBG, and CBC and their roles across various health conditions such as neurological disorders and chronic inflammation.
Notably, the Agency for Healthcare Research and Quality (AHRQ) has updated its
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.